The best way to manage amyotrophic lateral sclerosis (ALS) is through a multidisciplinary care plan tailored to a person’s specific medical needs. This includes ALS medications, supportive therapies, and symptom management.

Relyvrio (sodium phenylbutyrate and taurursodiol) is an oral treatment approved in the U.S. and Canada to help slow disease progression in adults with amyotrophic lateral sclerosis (ALS). The therapy has been shown in clinical trials to reduce functional decline and to significantly extend patient survival.

Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disease that affects the muscles involved in swallowing and breathing, potentially leading to issues such as malnutrition and weight loss, along with aspiration and lung infections.

Exercise can be beneficial for people with amyotrophic lateral sclerosis (ALS), helping to preserve muscle strength and mobility for as long as possible, and enhancing overall quality of life.

Many people have fasciculations, called muscle twitching, at some point. Often, it’s caused by drinking too much coffee, lack of sleep, or a trapped nerve. However, repeated episodes of fasciculations could be a sign of a neuromuscular disorder such as amyotrophic lateral sclerosis (ALS).

After a diagnosis of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative, muscle-wasting condition that doesn’t have a cure, your focus should be on what you can do to help maintain your quality of life.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons, eventually leading to disability and an inability to perform everyday tasks, including difficulty with eating and drinking.

Qalsody (tofersen) is an injection therapy conditionally approved in the U.S. for the treatment of amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene (SOD1-ALS).

Radicava (edaravone) is an approved infusion therapy used to slow functional decline in people with amyotrophic lateral sclerosis (ALS).

Exservan (riluzole oral film) is an approved oral treatment for amyotrophic lateral sclerosis (ALS). The medication can increase survival without the need for a tracheostomy — a tube inserted through the neck into the windpipe to help with breathing.